FDA Inspection 1058764 — Aizant Drug Research Solutions Private Ltd.

Aizant Drug Research Solutions Private Ltd. — FEI 3008243902

The FDA completed an inspection of Aizant Drug Research Solutions Private Ltd. on Jul 13, 2018 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 13, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hyderabad (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.